Blay JY - Search Results

1

Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on Sarcomas.

Casali PG, Le Cesne A, Poveda Velasco A, Kotasek D, Rutkowski P, Hohenberger P, Fumagalli E, Judson IR, Italiano A, Gelderblom H, Adenis A, Hartmann JT, Duffaud F, Goldstein D, Broto JM, Gronchi A, Dei Tos AP, Marréaud S, van der Graaf WT, Zalcberg JR, Litière S, Blay JY. Casali PG, et al. Among authors: blay jy. J Clin Oncol. 2015 Dec 20;33(36):4276-83. doi: 10.1200/JCO.2015.62.4304. Epub 2015 Nov 16. J Clin Oncol. 2015. PMID: 26573069 Clinical Trial.

2

Predictors of clinical response to interleukin-2--based immunotherapy in melanoma patients: a French multiinstitutional study.

Tartour E, Blay JY, Dorval T, Escudier B, Mosseri V, Douillard JY, Deneux L, Gorin I, Negrier S, Mathiot C, Pouillart P, Fridman WH. Tartour E, et al. Among authors: blay jy. J Clin Oncol. 1996 May;14(5):1697-703. doi: 10.1200/JCO.1996.14.5.1697. J Clin Oncol. 1996. PMID: 8622090

3

Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia.

Blay JY, Chauvin F, Le Cesne A, Anglaret B, Bouhour D, Lasset C, Freyer G, Philip T, Biron P. Blay JY, et al. J Clin Oncol. 1996 Feb;14(2):636-43. doi: 10.1200/JCO.1996.14.2.636. J Clin Oncol. 1996. PMID: 8636781

4

High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.

Blay JY, Conroy T, Chevreau C, Thyss A, Quesnel N, Eghbali H, Bouabdallah R, Coiffier B, Wagner JP, Le Mevel A, Dramais-Marcel D, Baumelou E, Chauvin F, Biron P. Blay JY, et al. J Clin Oncol. 1998 Mar;16(3):864-71. doi: 10.1200/JCO.1998.16.3.864. J Clin Oncol. 1998. PMID: 9508167

5

A risk model for thrombocytopenia requiring platelet transfusion after cytotoxic chemotherapy.

Blay JY, Le Cesne A, Mermet C, Maugard C, Ravaud A, Chevreau C, Sebban C, Guastalla J, Biron P, Ray-Coquard I. Blay JY, et al. Blood. 1998 Jul 15;92(2):405-10. Blood. 1998. PMID: 9657738 Free article.

6

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients.

Fizazi K, Dohollou N, Blay JY, Guérin S, Le Cesne A, André F, Pouillart P, Tursz T, Nguyen BB. Fizazi K, et al. Among authors: blay jy. J Clin Oncol. 1998 Dec;16(12):3736-43. doi: 10.1200/JCO.1998.16.12.3736. J Clin Oncol. 1998. PMID: 9850016

7

Risk model for severe anemia requiring red blood cell transfusion after cytotoxic conventional chemotherapy regimens. The Elypse 1 Study Group.

Ray-Coquard I, Le Cesne A, Rubio MT, Mermet J, Maugard C, Ravaud A, Chevreau C, Sebban C, Bachelot T, Biron P, Blay JY. Ray-Coquard I, et al. Among authors: blay jy. J Clin Oncol. 1999 Sep;17(9):2840-6. doi: 10.1200/JCO.1999.17.9.2840. J Clin Oncol. 1999. PMID: 10561360

8

Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens.

Blay JY, Judson I, Rodenhuis S, Hermans C, Smith M, van Glabbeke M, Verweij J. Blay JY, et al. Anticancer Drugs. 1999 Nov;10(10):873-7. doi: 10.1097/00001813-199911000-00002. Anticancer Drugs. 1999. PMID: 10630354 Clinical Trial.

9

Primary cerebral lymphomas: unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses. The FNCLCC. French Fédération Nationale des Centres de Lutte contre le Cancer.

Blay JY, Ongolo-Zogo P, Sebban C, Carrie C, Thiesse P, Biron P. Blay JY, et al. Ann Oncol. 2000;11 Suppl 1:39-44. Ann Oncol. 2000. PMID: 10707777 Review.

10

Effect of high-dose ifosfamide in advanced soft tissue sarcomas. A multicentre phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.

Nielsen OS, Judson I, van Hoesel Q, le Cesne A, Keizer HJ, Blay JY, van Oosterom A, Radford JA, Svancárová L, Krzemienlecki K, Hermans C, van Glabbeke M, Oosterhuis JW, Verweij J. Nielsen OS, et al. Among authors: blay jy. Eur J Cancer. 2000 Jan;36(1):61-7. doi: 10.1016/s0959-8049(99)00240-3. Eur J Cancer. 2000. PMID: 10741296 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,003 results

Search Page